Search Saint Luke's

Largest systematic study of atherosclerosis in ancient human remains suggests innate human predisposition to heart disease.

The use of prescription drugs for ADHD has significantly increased in the past few decades. James O'Keefe, MD studies the link between these medications and cardiovascular events.

Steven Tinkham was always proud of his active lifestyle. A born athlete, he grew up to find passion in biking and bodybuilding. But by the time he reached his 40s, an undiagnosed condition was beginning to take its toll—one joint at a time.

NIH awards more than $7.9 million grant to Healthcare Institute for Innovations in Quality

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

After severe back pain sidelined Ken from his adventure-packed life, he got a new lease on life through radiofrequency ablation treatment at Saint Luke’s Pain Management Clinic.

In 2011, Kelly McDaniel-Morales was 29 years old and seven months pregnant with her first daughter when she heard the words no expectant mother wants to hear: “You have cancer.”

What followed was a carefully orchestrated medical timeline that would forever change Kelly’s family.

In 2022, Kelsie O’Dell, 35, visited Edinburgh, Scotland, with a group of friends. On the medieval grounds of the great Borthwick Castle, Kelsie’s then-boyfriend surprised her by asking for her hand in marriage.

Saint Luke’s Cancer Institute genetic counselors help patients assess and manage future cancer risks, especially individuals who may have a hereditary cancer syndrome.

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.